Case management of malaria in pregnancy

dc.contributor.author	Mutabingwa, Theonest K.
dc.date.accessioned	2020-10-08T07:31:47Z
dc.date.available	2020-10-08T07:31:47Z
dc.date.issued	2007
dc.description.abstract	In all malarious areas, infection by any of the main human plasmodial species during pregnancy is detrimental to the mother and the fetus. These potentially fatal infections must be prevented, but when they develop they require prompt diagnosis and treatment. Current tools to detect malaria parasites in pregnant women are often not used and remain too insensitive to detect a low parasitaemia. The kinetics, safety, and efficacy of available antimalarial drugs are poorly documented because pregnant women are systematically excluded from clinical trials. A considerable effort, involving clinical trials, is urgently required to improve the diagnosis and case management of malaria during pregnancy if the morbidity and mortality of maternal malaria is to be reduced.	en_US
dc.identifier.citation	Nosten, F., McGready, R. and Mutabingwa, T., 2007. Case management of malaria in pregnancy. The Lancet infectious diseases, 7(2), pp.118-125.	en_US
dc.identifier.other	https://doi.org/10.1016/S1473-3099(07)70023-3
dc.identifier.uri	http://hdl.handle.net/123456789/622
dc.language.iso	en	en_US
dc.publisher	The Lancet infectious diseases	en_US
dc.subject	Pregnancy	en_US
dc.subject	Malarious areas	en_US
dc.subject	Plasmodium	en_US
dc.title	Case management of malaria in pregnancy	en_US
dc.type	Article	en_US